Open access · OA
via Europe PMC
Telomere length analysis using qPCR in aplastic anemia: prevalence and predictive value for germline mutation status.
Raina S, Jain A, Thakur V, Balakrishnan A, Jamwal M, Bhatia P, Bansal D, Malhotra P, Das R, Sreedharanunni S.
Blood research · 2026
Abstract
<h4>Purpose</h4>Telomere(definition) length analysis (TLA) is used to identify telomere biology disorders (TBD) in aplastic anemia (AA); however, the diagnostic performance of quantitative PCR (qPCR)-based TLA across germline mutation categories remains poorly defined.<h4>Methods</h4>A total of 305 consecutive patients with AA were prospectively enrolled over 3.5 years. All patients underwent age-adjusted qPCR-based TLA and comprehensive germline sequencing, including whole exome sequencing or blended genome-exome sequencing, and were classified as having inherited bone marrow failure syndrome (IBMFS) (Category 1, n = 40), a monoallelic carrier state (Category 2, n = 19), a variant of uncertain significance (VUS; Category 3, n = 39), or AA without germline variants (Category 4, n = 207).<h4>Results</h4>Shortened telomere length (TL) (≤ 10th percentile) was present in 37.7% of patients, and very short TL (≤ 1st percentile) was present in 14.8%. The degree of shortening varied by etiology: 71.4% of confirmed TBD gene carriers had shortened TL compared with 31.6% of carriers of biallelic variants in Fanconi anemia pathway genes and 37.7% of patients with acquired AA. TL did not distinguish confirmed IBMFS from acquired AA across the full disease spectrum; however, normal TL (> 10th percentile) excluded TBD-associated IBMFS (TBD-IBMFS) with a negative predictive value of 98.5%. Very short TL (≤ 1st percentile) had a positive predictive value of only 12.9% for TBD-IBMFS and was also observed in 13.0% of acquired-AA patients.<h4>Conclusions</h4>In unselected patients with AA, qPCR-based TLA does not distinguish inherited from acquired disease across the full spectrum of IBMFS; however, normal TL substantially lowers the likelihood of TBD-IBMFS. Very short TL is not specific to constitutional telomeropathy and should be interpreted with caution when adjudicating TBD variants of uncertain significance.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1007/s44313-026-00182-x
- Canonical
- link ↗
- Fetched
- 2026-10-06 MST
Cite this
APA
S, R., A, J., V, T., A, B., M, J., P, B., D, B., P, M., R, D., & S., S. (2026). Telomere length analysis using qPCR in aplastic anemia: prevalence and predictive value for germline mutation status. <em>Blood research</em>. https://doi.org/10.1007/s44313-026-00182-x
Vancouver
S R, A J, V T, A B, M J, P B, et al. Telomere length analysis using qPCR in aplastic anemia: prevalence and predictive value for germline mutation status. Blood research. 2026. doi:10.1007/s44313-026-00182-x.
BibTeX
@article{raina2026Telome,
title = {Telomere length analysis using qPCR in aplastic anemia: prevalence and predictive value for germline mutation status.},
author = {Raina S and Jain A and Thakur V and Balakrishnan A and Jamwal M and Bhatia P and Bansal D and Malhotra P and Das R and Sreedharanunni S.},
journal = {Blood research},
year = {2026},
doi = {10.1007/s44313-026-00182-x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
Blood 2025
Open access · OA
Telomere attrition is common in patients with germline RUNX1 pathogenic variants
Journal of the Neurological Sciences 2013
Citation only
Telomere length distribution of circulating leukocytes in patients with Alzheimer's disease
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
The Lancet 2009
Citation only